Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Toshiki,Fukasawa ^[1] ; Etsuro,Nakanishi ^[2] ; Hiroo,Shimoda ^[3] ; Katsumi,Shinoda ^[3] ; Satoru,Ito ^[4] ; Shinji,Asada ^[3] ; Satomi,Yoshida ^[5] ; Sachiko,Tanaka-Mizuno ^[1] ; Kayoko,Mizuno ^[1] ; Ryosuke,Takahashi ^[2] ; Koji,Kawakami ^[6]

作者单位： Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan; Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. ^[1] Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ^[2] Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan. ^[3] Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan; Pharmacovigilance Division, Kyowa Kirin Co., Ltd., Tokyo, Japan. ^[4] Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. ^[5] Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Electronic address: kawakami.koji.4e@kyoto-u.ac.jp. ^[6]

关键词 Adherence Group-based trajectory modeling Heterogeneity Istradefylline Parkinson's disease